Medroza-40 from Healthgate is a prescription corticosteroid injection. It is supplied as a sterile, aqueous (water-based) suspension in a single-dose vial. It contains Methylprednisolone Acetate, a powerful anti-inflammatory and immunosuppressive agent. This medicine must only be administered via intramuscular (I.M.), intra-articular (into a joint), or soft tissue injection. It is specifically formulated to provide local or systemic relief from various inflammatory and allergic conditions.
This unit contains:
1 Vial of Sterile Aqueous Suspension: 1 ml containing 40 mg of Methylprednisolone Acetate IP.
Medroza-40 is a sterile aqueous suspension of Methylprednisolone Acetate for potent anti-inflammatory and immunosuppressive therapy. It is indicated for the treatment of severe allergic, dermatologic, gastrointestinal, hematologic, ophthalmic, respiratory, and rheumatic disorders, as well as for control of specific types of cancer. Strictly not for Intravenous (I.V.) use.
| Pros | Cons |
| Potent Anti-Inflammatory: Provides highly effective relief for severe inflammatory conditions across multiple systems. | Requires Healthcare Professional Administration: Accurate preparation and specialized I.M., intra-articular, or soft tissue delivery must be done by a trained professional (doctor, nurse). |
| Versatile Delivery: Can be injected intramuscularly for systemic effects or locally into specific tissues/joints for concentrated therapy. | Not for Intravenous (I.V.) Use: The box label strictly warns “Not for Intravenous use.” Mistaken I.V. administration can be fatal. |
| controlled Dosing: Single-dose vial provides precise, tailorable delivery suitable for a variety of critical conditions. | Side Effects: Common side effects include upset stomach, increased appetite, insomnia, or dizziness. Less common but serious effects, like allergic reactions, renal changes, or bone issues, can occur. |
| Alternative Route: Vital treatment option for patients who cannot take or tolerate oral steroids, or when immediate systemic action is required. | interaction risk: Medroza-40 has potential drug interactions that must be carefully managed. |
WARNING: FOR INTRAMUSCULAR (I.M.), INTRA-ARTICULAR, AND SOFT TISSUE INJECTION ONLY. STERNLY AVOID INTRAVENOUS (I.V.) INFUSION.
This product is for single-dose administration by a qualified healthcare professional only. Do not attempt to self-administer.
Preparation (Suspension): Immediately before drawing up the solution, a healthcare professional will thoroughly shake the vial to ensure the suspension is uniform.
Inspection: The resulting suspension should be a uniform, white, opaque liquid. It must be visually inspected for particulate matter and discoloration before use. It should not be used if it is discolored or contains any abnormal particles.
Administration:
Intramuscular (I.M.): The reconstituted suspension can be injected deeply into a large muscle mass.
Intra-Articular: The suspension can be injected into a specific joint space as a sterile procedure.
Soft Tissue: The suspension can be injected into specific soft tissue areas for localized treatment.
Use Immediately: The suspension should be used immediately after preparation. Any unused portion must be discarded.
Healthgate is a leading respiratory pharma company in India, focused on delivering high-quality medicines for asthma, COPD, bronchitis, and other breathing disorders. With advanced formulations, strict quality standards, and a patient-centric approach, Healthgate ensures safe, effective, and affordable respiratory healthcare solutions across the nation through strong distribution support.
© 2025 Created with Hydra Infotech
This website uses cookies to provide you with the best browsing experience.